VerifyNow P2Y12 Parameters in Non-Drug Users

被引：0
|
作者：
Lee, Young Kyung [1 ]
机构：
[1] Hallym Univ, Coll Med, Anyang, Gyeonggido, South Korea
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2012年 / 138卷
关键词：
D O I：
10.1093/ajcp/138.suppl2.124
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
342
引用
收藏
页码：A342 / A342
页数：1
相关论文
共 50 条
  • [21] Life chaos among drug users and non-drug users
    Lasopa, Sonam Ongmu
    Vaddiparti, Krishna
    Striley, Catherine Woodstock
    Cottler, Linda
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E115 - E115
  • [22] Point of Care Tests VerifyNow P2Y12 and INNOVANCE PFA P2Y Compared to Light Transmittance Aggregometry After Fibrinolysis
    Roule, Vincent
    Ardouin, Pierre
    Repesse, Yohan
    Le Querrec, Agnes
    Blanchart, Katrien
    Lemaitre, Adrien
    Sabatier, Remi
    Borel-Derlon, Annie
    Beygui, Farzin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (07) : 1109 - 1116
  • [23] The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions
    Janssen, P. W. A.
    Bergmeijer, T. O.
    Godschalk, T. C.
    Le, T. T. D.
    Breet, N. J.
    Kelder, J. C.
    Hackeng, C. M.
    Ten Berg, J. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (04) : 618 - 623
  • [24] Comparative effectiveness of the verifynow P2Y12 Test and light transmittance aggregometry for detecting the antiplatelet effect of clopidogrel
    Dahlen, J. R.
    Serebruany, V. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1185 - 1185
  • [25] Potential for drug-drug interaction between vonoprazan and prasugrel on antiplatelet effect assessed by VerifyNow P2Y12 assay in patients with coronary artery disease
    Koga, S.
    Ikeda, S.
    Akashi, R.
    Yamagata, Y.
    Yonekura, T.
    Kawano, H.
    Maemura, K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 4006 - 4006
  • [26] Verifynow P2Y12 Assay With Regard to Cytochrome P450 2C19 Polymorphisms and Stroke Recurrence
    Han, Sang Won
    Park, Joong Hyun
    Cheon, Kyeong Yeol
    Lee, Kyung-Yul
    STROKE, 2018, 49
  • [27] Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice
    Golino, Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 : S22 - S30
  • [28] Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness
    Kakouros, N.
    Kickler, T. S.
    Laws, K. M.
    Rade, J. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (10) : 1814 - 1822
  • [29] Precision of VerifyNow P2Y12 Assessment of Clopidogrel Response in Patients Undergoing Cerebral Aneurysm Flow Diversion
    Bender, Matthew T.
    Zarrin, David A.
    Campos, Jessica K.
    Jiang, Bowen
    Chandra, Arun
    Vo, Chau D.
    Caplan, Justin M.
    Huang, Judy
    Tamargo, Rafael J.
    Lin, Li-Mei
    Colby, Geoffrey P.
    Coon, Alexander L.
    NEUROSURGERY, 2019, 85 (04) : 543 - 549
  • [30] Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists
    Richard C. Becker
    Journal of Thrombosis and Thrombolysis, 2009, 28 : 513 - 514
12345